Internal Medicine • Research • Visualized VISUALIZED: Evaluating Secondary T-Cell Malignancies as Adverse Reactions to CAR T-Cell Therapy Add Comment1 min read Read further: Evaluating Secondary T-Cell Malignancies as Adverse Reactions to CAR T-Cell Therapy FacebookXPinterestLinkedIn
Article NL V.12 (2025) • Internal Medicine • Research Increased Risk of PTLD and Graft Failure in EBV D+/R−... 3 min read
Article NL V.12 (2025) • Internal Medicine • Research The Link Between Trauma and Endometriosis: Insights... 3 min read
Article NL V.12 (2025) • Internal Medicine • Practice Global Priorities for Menopause Research: Key Findings... 4 min read
Article NL V.12 (2025) • Internal Medicine • Practice Concussion Risks in Women’s Rugby: Epidemiology... 3 min read